-
Merit Medical enrols first subject in study of Wrapsody CIE device
19 Aug 2025 15:27 GMT
Merit Medical Systems has enrolled the … treated with the device.
Merit Medical Systems CEO and chairman Fred … the device or percutaneous transluminal angioplasty (PTA) was used for … Wrapsody CIE.
In May 2025, Merit Medical further expanded its operations by …
-
First Patient Enrolled in Merit Medical’s WRAPSODY (WRAP) North America Registry
18 Aug 2025 13:25 GMT
… , 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI … CIE or percutaneous transluminal angioplasty (PTA). In the … are the property of Merit Medical Systems, Inc., its subsidiaries … ;Media Inquiries
Sarah Comstock
Merit Medical
+1-801-432-2864 …
-
Health Canada approves Merit Medical Systems’ Wrapsody CIE device
07 May 2025 13:02 GMT
Health Canada has approved Merit Medical Systems’ Wrapsody cell-impermeable endoprosthesis … rates against percutaneous transluminal angioplasty (PTA).
Merit Medical Systems CEO and chairman … in Brazil.
In March, Merit Medical enrolled the first subject in …
-
Merit Medical Announces Health Canada Approval of the WRAPSODY® Cell-Impermeable Endoprosthesis
06 May 2025 13:25 GMT
… compared to percutaneous transluminal angioplasty (PTA). At six … For additional information on Merit Medical’s WAVE trial, please … are the property of Merit Medical Systems, Inc., its … Media Inquiries
Sarah Comstock
Merit Medical
+1-801-432-2864 …
-
Merit Medical Releases 12-Month Efficacy Results of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE)
25 Mar 2025 13:25 GMT
… =122) or standard percutaneous transluminal angioplasty (PTA, n=123). Treatment efficacy … Brazil. For additional information on Merit Medical’s WAVE trial, please visit … release are the property of Merit Medical Systems, Inc., its subsidiaries, or …
-
Merit Medical touts positive six-month data from WAVE trial
17 Sep 2024 22:34 GMT
Merit Medical has revealed positive six-month … primary patency at six months.
Merit Medical’s device, named WRAPSODY, is … ’s treatment or percutaneous transluminal angioplasty (PTA), the standard-of-care …
-
Merit Medical’s WRAPSODY WAVE Trial Demonstrates Superior Patency versus Standard of Care in AV Fistula Patients
16 Sep 2024 12:30 GMT
… to WRAPSODY or percutaneous transluminal angioplasty (PTA). Target lesion primary … Union. For additional information on Merit Medical’s WAVE study, please visit … forward-looking statements. ABOUT MERIT MEDICAL Founded in 1987, Merit Medical Systems, Inc. is …
-
Merit Medical to Present 6-Month Outcomes from Randomized Arm of WRAPSODY™ Arteriovenous Access Efficacy (WAVE) Pivotal Study at Two Upcoming Medical Meetings
01 Aug 2024 20:05 GMT
… of care with percutaneous transluminal angioplasty (PTA). Safety and performance … ;study/NCT04540302. ABOUT MERIT MEDICAL Founded in 1987, Merit Medical Systems, Inc. is … release are the property of Merit Medical Systems, Inc., its subsidiaries, …
-
Merit Medical Launches basixSKY™ Inflation Device
21 May 2024 13:25 GMT
… and in kits with Merit Angioplasty Packs, configured to offer complementing … . Endovascular interventions, such as balloon angioplasty and stent placement procedures used … best patient care.” ABOUT MERIT MEDICAL Founded in 1987, Merit Medical Systems, Inc. is …
-
Percutaneous Transluminal Coronary Angioplasty Dilation Catheters Market Set For 6.6% Growth, Reaching $2.37 Billion
12 Dec 2024 13:30 GMT
…
The percutaneous transluminal coronary angioplasty PTCA dilation catheters market size … #47;percutaneous-transluminal-coronary-angioplasty-ptca-dilation-catheters-global- … Medical Technology Beijing Co Ltd., Merit Medical Systems Inc., Cordis Corporation, …